- Home
- SNSE vs MCVT Comparison
SNSE vs MCVT Comparison
Compare SNSE & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- MCVT
- Stock Information
- Founded
- SNSE 2005
- MCVT 2007
- Country
- SNSE United States
- MCVT United States
- Employees
- SNSE N/A
- MCVT N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- MCVT Finance Companies
- Sector
- SNSE Health Care
- MCVT Finance
- Exchange
- SNSE Nasdaq
- MCVT Nasdaq
- Market Cap
- SNSE 9.3M
- MCVT 9.3M
- IPO Year
- SNSE 2021
- MCVT N/A
- Fundamental
- Price
- SNSE $0.38
- MCVT $1.41
- Analyst Decision
- SNSE Strong Buy
- MCVT
- Analyst Count
- SNSE 4
- MCVT 0
- Target Price
- SNSE $4.25
- MCVT N/A
- AVG Volume (30 Days)
- SNSE 8.3M
- MCVT 29.4K
- Earning Date
- SNSE 05-08-2025
- MCVT 05-15-2025
- Dividend Yield
- SNSE N/A
- MCVT N/A
- EPS Growth
- SNSE N/A
- MCVT N/A
- EPS
- SNSE N/A
- MCVT 0.18
- Revenue
- SNSE N/A
- MCVT $3,301,119.00
- Revenue This Year
- SNSE N/A
- MCVT N/A
- Revenue Next Year
- SNSE N/A
- MCVT N/A
- P/E Ratio
- SNSE N/A
- MCVT $8.06
- Revenue Growth
- SNSE N/A
- MCVT 0.07
- 52 Week Low
- SNSE $0.25
- MCVT $1.13
- 52 Week High
- SNSE $1.94
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- SNSE 48.32
- MCVT 39.70
- Support Level
- SNSE $0.33
- MCVT $1.36
- Resistance Level
- SNSE $0.39
- MCVT $1.51
- Average True Range (ATR)
- SNSE 0.05
- MCVT 0.12
- MACD
- SNSE 0.00
- MCVT 0.02
- Stochastic Oscillator
- SNSE 52.68
- MCVT 55.17
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.